Primary Hyperoxaluria Type 1 (PH1)
View the latest scientific data presented at congress events in the past 2 years and discover peer-reviewed publications related to PH1.
The information on this page pertains to select congress and publication resources. It is not intended to serve as a comprehensive list of all congress and publications resources.
Congresses
Primary Hyperoxaluria Type 1 (PH1)
European Society for Paediatric Nephrology (ESPN) 2025
Primary Hyperoxaluria Type 1 (PH1)
International Pediatric Transplant Association (IPTA) 2025
Primary Hyperoxaluria Type 1 (PH1)
European Society for Paediatric Urology (ESPU) 2025
Primary Hyperoxaluria Type 1 (PH1)
American Urological Association (AUA) 2025
Primary Hyperoxaluria Type 1 (PH1)
American Society of Pediatric Nephrology (ASPN)/Pediatric Academic Societies (PAS) 2025
Primary Hyperoxaluria Type 1 (PH1)
National Kidney Foundation (NKF) 2025
Publications
Primary Hyperoxaluria Type 1 (PH1)
Qualitative assessment of the patient experience of primary hyperoxaluria type 1: an observational study
BMC Nephrology
Primary Hyperoxaluria Type 1 (PH1)
Quantification of oxalate by novel LC-MS/MS: assay development, validation and application in lumasiran clinical trials
Bioanalysis
Primary Hyperoxaluria Type 1 (PH1)
Estimating health state utilities in primary hyperoxaluria type 1: a valuation study
Journal of Medical Economics
Primary Hyperoxaluria Type 1 (PH1)
Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trial
Pediatric Nephrology
Primary Hyperoxaluria Type 1 (PH1)
Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial
American Journal of Kidney Diseases
Primary Hyperoxaluria Type 1 (PH1)
Randomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1
Kidney International Reports
